The current share price of Sun Pharmaceutical Industries is ₹1,631.20, with a market capitalization of ₹3,92,567.19. The stock is currently trading at the P/E ratio of 37.85x and it has a Debt/Equity ratio of 0.03x.
In Jun 2025, the company announced sales of ₹13,851.00 and net profit of ₹2,293.00. TTM ROE stands at 15.13% with promoter holding of 54.48%.
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio.
Fundamentals
Key Metrics
Profitability Ratios
Liquidity Ratios
Valuation Ratios
Solvency Ratios
Dividend Metrics
Technicals
Daily Moving Averages (DMA)
Price Trend
Price Chart
Volume Chart
Stock Returns & Corporate Actions
You can also calculate any period's returns Here..